Kari Hoffman.

Kari Hoffman

Associate professor of psychology
Vanderbilt University

Kari Hoffman is associate professor of psychology at Vanderbilt University, specializing in computational primate neuroethology within the Vanderbilt Brain institute, the Data Science Institute, the Department of Biomedical Engineering and the Department of Psychology. Her research investigates how neural circuits organize and adapt to allow an organism to build and apply knowledge effectively.

Hoffman’s lab uses naturalistic, contingent tasks with primate models to understand brain function in real-world contexts, focusing on how memories are structured over time. To understand neural population organization during and after learning, her team uses high-density, wireless multisite ensemble recordings. These neural and behavioral measures are then compared with computational models of learning and generalization.

Hoffman earned her Ph.D. in systems and computational neuroscience from the University of Arizona and completed a postdoctoral fellowship in the lab of Nikos Logothetis at the Max Planck Institute in Tübingen, Germany. Her contributions to neuroscience have been recognized with Sloan and Whitehall fellowships, an Ontario Early Researcher Award, and designation as a Kavli fellow.

Explore more from The Transmitter

Headshots of Yale researchers Yong-Hui Jiang and Jiangbing Zhou.

Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions

Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.

By Natalia Mesa
3 June 2026 | 11 min read

What counts as a ‘naturalistic’ behavior?

Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.

By Paul Middlebrooks
3 June 2026 | 1 min read
Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read